Literature DB >> 7495487

AIDS: a disease of impaired Th-cell renewal?

J L Heeney1.   

Abstract

Individuals who are infected with human immunodeficiency virus (HIV) and develop AIDS are characterized by the progressive loss of T helper (Th) cells, together with an increase in virus load. Despite a remarkable similarity to humans, and their susceptibility to persistent HIV-1 infection, chimpanzees have a relative resistance to the development of AIDS. Here, Jonathan Heeney proposes that the critical underlying event perpetuating the progression to AIDS is the impairment of the immunological microenvironment necessary for competent, antigen-specific, Th-cell renewal. Survival is dependent on the host's ability to preserve the immunological infrastructure sufficiently in order to maintain the capacity for renewal of a balanced, competent Th-cell population.

Entities:  

Mesh:

Year:  1995        PMID: 7495487     DOI: 10.1016/0167-5699(95)80043-3

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  14 in total

1.  Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees.

Authors:  T Beaumont; S Broersen; A van Nuenen; H G Huisman; A M de Roda Husman; J L Heeney; H Schuitemaker
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Natural SIV hosts: showing AIDS the door.

Authors:  Ann Chahroudi; Steven E Bosinger; Thomas H Vanderford; Mirko Paiardini; Guido Silvestri
Journal:  Science       Date:  2012-03-09       Impact factor: 47.728

3.  The central region of the major histocompatibility complex contains a sequence with similarity to the pol gene of Moloney retroviruses.

Authors:  S Gaudieri; J K Kulski; R L Dawkins
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency.

Authors:  S L Waldrop; C J Pitcher; D M Peterson; V C Maino; L J Picker
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

5.  Transmission of simian immunodeficiency virus SIVcpz and the evolution of infection in the presence and absence of concurrent human immunodeficiency virus type 1 infection in chimpanzees.

Authors:  Jonathan L Heeney; Erik Rutjens; Ernst J Verschoor; Henk Niphuis; Peter ten Haaft; Scott Rouse; Hazel McClure; Sunita Balla-Jhagjhoorsingh; Willy Bogers; Mary Salas; Kathy Cobb; Luc Kestens; David Davis; Guido van der Groen; Valerie Courgnaud; Martine Peeters; Krishna K Murthy
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Thymic lesions in cats infected with a pathogenic molecular clone or an ORF-A/2-deficient molecular clone of feline immunodeficiency virus.

Authors:  R M Norway; P C Crawford; C M Johnson; A Mergia
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Antiviral therapy reduces viral burden but does not prevent thymic involution in young cats infected with feline immunodeficiency virus.

Authors:  K A Hayes; A J Phipps; S Francke; L E Mathes
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 8.  T helper cell activation and human retroviral pathogenesis.

Authors:  K F Copeland; J L Heeney
Journal:  Microbiol Rev       Date:  1996-12

9.  Nef proteins from simian immunodeficiency virus-infected chimpanzees interact with p21-activated kinase 2 and modulate cell surface expression of various human receptors.

Authors:  Frank Kirchhoff; Michael Schindler; Nicola Bailer; G Herma Renkema; Kalle Saksela; Volker Knoop; Michaela C Müller-Trutwin; Mario L Santiago; Frederic Bibollet-Ruche; Matthias T Dittmar; Jonathan L Heeney; Beatrice H Hahn; Jan Münch
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4(+) T cells.

Authors:  C Berndt; B Möpps; S Angermüller; P Gierschik; P H Krammer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.